Yahoo

Kureha (TSE:4023) Jumps Back Into Focus, Is The Upside Already Priced In?

Kureha (TSE:4023) has come back into focus after its latest trading session, with the share price closing at ¥4,195 on 29 October 2026 and recent returns drawing fresh attention from investors.

Recent trading has added some short term momentum for Kureha, with a 1 day share price return of 4.48% and a 7 day gain of 8.12%, even though the 90 day share price return declined 2.21% while the 1 year total shareholder return reached 19.64%.

Scan how Kureha compares to other materials players showing fresh momentum by reviewing our curated list of 16 high quality undervalued stocks .

The recent jump in Kureha shares raises a simple fork in the road. Has the bulk of the easy gain already played out, or do the current fundamentals still leave meaningful upside on the table once valuation is unpacked next?

Preferred Multiple of Price-to-Sales: Is it justified?

Kureha now trades on a P/S ratio of roughly 1x, while our data points to a fair P/S closer to 0.8x and a sector average of 0.7x. That gap suggests the recent share price strength is being supported by expectations that reach beyond what current revenues and profitability show.

The price-to-sales ratio compares the market value of the equity to its annual revenue. For a materials group like Kureha, which generated approximately ¥167.2b in sales and currently reports a loss of ¥8.5b, P/S is often used because earnings are not a stable anchor yet. In this case, investors are paying around 1x sales for a business that is still unprofitable and carries a high level of debt, even though earnings are forecast to grow 56.14% per year and the company is expected to become profitable within three years.

Against the broader JP Chemicals industry, the 1x multiple looks demanding. Peers sit closer to 0.7x, and the estimated fair P/S ratio of 0.8x points to a level the market could move towards if optimism around future earnings and cash generation cools. With the SWS DCF model indicating that the current ¥4,195 price is above an estimated future cash flow value of ¥2,562.85, the valuation message is consistent. Growth expectations are being priced in quite aggressively rather than conservatively.

Explore the SWS fair ratio for Kureha.

Result: Price-to-Sales of 1x (OVERVALUED)

Still, the current Kureha share price already sits above the average analyst target of ¥3,798, while ongoing losses and high debt levels could quickly reduce that optimism.

Find out about the key risks to this Kureha narrative .

Another View: What The DCF Model Says About Kureha

A different lens tells a similar story. The SWS DCF model estimates Kureha's future cash flow value at about ¥2,562.85 per share, well below the current ¥4,195 level, which points to an overvalued picture rather than a hidden bargain on this metric.

That gap matters because it suggests expectations baked into the market price could be ahead of the cash the business is projected to generate. It raises a simple question for you as an investor: Is the premium you pay today worth the uncertainty around those future cash flows, or is patience the better trade off?

Look into how the SWS DCF model arrives at its fair value.

4023 Discounted Cash Flow as at Nov 2026
4023 Discounted Cash Flow as at Nov 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( check out Kureha for example ). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 16 high quality undervalued stocks . If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this combination of overvaluation signals and future potential around Kureha seems finely balanced, consider acting promptly and stress test the numbers for yourself using the 1 key reward and 2 important warning signs .

Looking for more investment ideas beyond Kureha?

Do not stop your research with Kureha. Use this moment to widen your watchlist, compare different setups, and pressure test your thesis against fresh ideas.

  • Target potential mispricings by running through our carefully filtered 16 high quality undervalued stocks built around strong fundamentals and supportive balance sheets.

  • Strengthen your income toolkit by scanning a curated universe of higher yielding opportunities with the 28 dividend fortresses , then weigh them against your current holdings.

  • Lower portfolio stress by reviewing a 23 resilient stocks with low risk scores that focuses on resilient businesses with more conservative risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include 4023.T .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: